Sign in

CIK 0001123494

  • Non-accelerated filer
  • Smaller reporting company

HARVARD BIOSCIENCE INC

Sign in to watch
Ticker
HBIO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043306140
Phone
+1 508-893-8999
Business address
84 OCTOBER HILL RD, HOLLISTON, MA, 01746
  1. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $4.38 ($109,500)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 48,373 shares (to pay taxes)
  3. 4 Grant or award Director acquired 25,554 shares (grant or award)
  4. 4 Grant or award Director acquired 25,554 shares (grant or award)
  5. 4 Grant or award Director acquired 25,554 shares (grant or award)
  6. 4 Grant or award Director acquired 31,516 shares (grant or award)
  7. 4 Open-market buy Director bought 30,000 shares at an average $2.64 ($79,290)
  8. 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $2.64 ($105,400)
  9. 4 Grant or award Chief Executive Officer acquired 692,750 shares (grant or award)
  10. 4 Grant or award Interim CFO acquired 82,634 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 9,960 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 125,509 shares (to pay taxes)
  14. 4 Open-market buy Chief Executive Officer bought 30,000 shares at an average $2.51 ($75,300)
  15. 4 Other disposition Director disposed of 108,715 shares (other)
  16. 4 Open-market buy Director bought 9,291 shares at $3.41 ($31,682)
  17. 4 Open-market buy Director bought 25,535 shares at an average $3.27 ($83,385)
  18. 4 Open-market buy Director bought 13,857 shares at an average $3.21 ($44,414)
  19. 4 Open-market buy Director bought 10,759 shares at an average $3.27 ($35,186)
  20. 4 Open-market buy Chief Executive Officer bought 40,000 shares at $3.19 ($127,600)

Page 3 of 32 · 623 filings